Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mayumi Nishimoto"'
Prognostic impact of TP53INP1 gene expression in estrogen receptor α-positive breast cancer patients
Autor:
Katsuhiro Okuda, Yu Dong, Satoru Takahashi, Tatsuya Toyama, Sayaka Nishikawa, Naoto Kondo, Tomoka Hisada, Yumi Wanifuchi-Endo, Mayumi Nishimoto, Hiroshi Sugiura, Hiroyuki Kato, Yukari Hato
Publikováno v:
Japanese Journal of Clinical Oncology. 49:567-575
BACKGROUND Tumor protein 53-induced nuclear protein 1 (TP53INP1) is a key stress protein with tumor suppressor function. Several studies have demonstrated TP53INP1 downregulation in many cancers. In this study, we investigated the correlations of TP5
Autor:
Hiroyuki Kato, Mayumi Nishimoto, R Nakanishi, Sayaka Nishikawa, Katsuhiro Okuda, Tatsuya Toyama, Yu Dong, Naoto Kondo, Tomoka Hisada, Yumi Endo, S. Takahashi, Yukari Hato
Publikováno v:
Cancer Research. 78:P3-08
Background: Breast cancer cells disseminate to the bone marrow and form bone metastases in a large majority of late-stage patients. Retinoic Acid-Induced 2 (RAI2) was reported as a putative suppressor of early hematogenous dissemination of tumor cell
Autor:
Satoru Takahashi, Yukari Hato, Sayaka Nishikawa, Yu Dong, Tatsuya Toyama, Naoto Kondo, Yumi Endo, Tomoka Hisada, Mayumi Nishimoto
Publikováno v:
Cancer Research. 77:P2-03
Background: Although taxanes are a mainstay of breast cancer treatment, some cases are resistant to these drugs. This is a crucial issue in breast cancer therapy. In the emerging era of next-generation sequencing, it is possible to obtain extensive g
Autor:
Tatsuya Toyama, Naoto Kondo, Tomoka Hisada, Y Wanifuchi, Sayaka Nishikawa, T-S Kim, Mayumi Nishimoto, Yukari Hato
Publikováno v:
Cancer Research. 77:P6-07
Background : Inositol polyphosphate 5-phosphatase PIPP (INPP5J) has been identified as a suppressor of oncogenic PI3K/Akt signaling in breast cancer.INPP5J depletion increases transformation and accelerates oncogene-driven tumor growth in vivo, while
Autor:
Astushi Yoshida, Mayumi Nishimoto
Publikováno v:
Iryo To Shakai. 19:221-233
療養病床には医療保険適用の医療療養病床と介護保険適用の介護療養病床の2タイプがあり,前者には医療の必要性が高い患者を,後者には医療の必要性が低い患者を受け入れることを
Autor:
Mayumi Nishimoto, Satoru Takahashi, Hiroyuki Kato, Yumi Endo, Tatsuya Toyama, Yukari Hato, Naoto Kondo, Ryoichi Nakanishi, Yu Dong, Nobuyasu Yoshimoto, Tomoko Asano
Publikováno v:
Breast cancer (Tokyo, Japan). 23(6)
Human epidermal growth factor receptor 2 (HER2) gene amplification/overexpression is a major therapeutic target in breast cancer, and has been introduced as a predictive biomarker to identify patients who may benefit from therapy with anti-HER2 agent